相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease
An-Qi Dong et al.
ACTA PHARMACOLOGICA SINICA (2023)
Maraviroc promotes recovery from traumatic brain injury in mice by suppression of neuroinflammation and activation of neurotoxic reactive astrocytes
Xi-Lei Liu et al.
NEURAL REGENERATION RESEARCH (2023)
NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome
Katerina Theodoropoulou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)
Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy
Carolina A. Moraes et al.
MOLECULAR NEUROBIOLOGY (2023)
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease
Alexander Grotemeyer et al.
JOURNAL OF NEUROINFLAMMATION (2023)
The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice
Jia-Mei Li et al.
JOURNAL OF NEUROINFLAMMATION (2023)
HDAC Inhibitor SAHA Alleviates Pyroptosis by up-regulating miR-340 to Inhibit NEK7 Signaling in Subarachnoid Hemorrhage
Kui Luo et al.
NEUROCHEMICAL RESEARCH (2023)
Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons
Sebastiaan Moonen et al.
ACTA NEUROPATHOLOGICA (2023)
Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration
Xinxin Ma et al.
ADVANCED MATERIALS (2022)
Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation
Ting Xu et al.
CELL DEATH AND DIFFERENTIATION (2022)
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease
Adrianne F. Pike et al.
JOURNAL OF NEUROINFLAMMATION (2022)
NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis
Poulomi Banerjee et al.
JOURNAL OF PATHOLOGY (2022)
Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide
Kai Wang et al.
NEUROCHEMISTRY INTERNATIONAL (2022)
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Yawen Cai et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Idebenone Regulates Aβ and LPS-Induced Neurogliosis and Cognitive Function Through Inhibition of NLRP3 Inflammasome/IL-1β Axis Activation
Hyun-ju Lee et al.
FRONTIERS IN IMMUNOLOGY (2022)
Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
Cong Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal α-synuclein accumulation
Yu Ren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Investigating the NLRP3 inflammasome and its regulator miR-223-3p in multiple sclerosis and experimental demyelination
Dylan A. Galloway et al.
JOURNAL OF NEUROCHEMISTRY (2022)
Downregulated XBP-1 Rescues Cerebral Ischemia/Reperfusion Injury-Induced Pyroptosis via the NLRP3/Caspase-1/GSDMD Axis
Yueting Zhang et al.
MEDIATORS OF INFLAMMATION (2022)
Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome
Julien Moretti et al.
NATURE IMMUNOLOGY (2022)
Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease
Nikhil Panicker et al.
NEURON (2022)
Hydrogen Attenuated Inflammation Response and Oxidative in Hypoxic Ischemic Encephalopathy via Nrf2 Mediated the Inhibition of NLRP3 and NF-κB
Yajiao Hu et al.
NEUROSCIENCE (2022)
The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson's Disease by Inhibiting the NF-?B/NLRP3 Pathway
Shuhan Liu et al.
FRONTIERS IN PHARMACOLOGY (2022)
HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells
Feng Yao et al.
CELL DEATH DISCOVERY (2022)
β-Hydroxybutyrate alleviates pyroptosis in MPP+/MPTP-induced Parkinson's disease models via inhibiting STAT3/NLRP3/GSDMD pathway
Ziying Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages
Yanhui Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex
Evelien Van Schoor et al.
ACTA NEUROPATHOLOGICA (2022)
Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model
Haoyun Zhang et al.
BMC NEUROSCIENCE (2022)
Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson's disease
Kristine E. Zengeler et al.
NEURON (2022)
Novel inflammasome and oxidative modulators in Parkinson's disease: A prospective study
Akash Roy et al.
NEUROSCIENCE LETTERS (2022)
C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect
Ru-Huei Fu et al.
CELLS (2022)
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Liliang Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
Swagata Ghatak et al.
MOLECULAR PSYCHIATRY (2021)
1-Deoxysphingolipids cause autophagosome and lysosome accumulation and trigger NLRP3 inflammasome activation
Mario A. Lauterbach et al.
AUTOPHAGY (2021)
Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease
Yue Qin et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy
Tao Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
Liudmila Andreeva et al.
CELL (2021)
NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury
Xubiao Ji et al.
EXPERIMENTAL CELL RESEARCH (2021)
Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidification
Shi Yu et al.
FEBS JOURNAL (2021)
ANP and BNP Exert Anti-Inflammatory Action via NPR-1/cGMP Axis by Interfering with Canonical, Non-Canonical, and Alternative Routes of Inflammasome Activation in Human THP1 Cells
Letizia Mezzasoma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara S. Rodrigues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Recruitment of pro-IL-1α to mitochondrial cardiolipin, via shared LC3 binding domain, inhibits mitophagy and drives maximal NLRP3 activation
Jargalsaikhan Dagvadorj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Electroacupuncture Ameliorates Neuroinflammation-Mediated Cognitive Deficits through Inhibition of NLRP3 in Presenilin1/2 Conditional Double Knockout Mice
Kun Li et al.
NEURAL PLASTICITY (2021)
p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
Jialong Chen et al.
JOURNAL OF NEUROINFLAMMATION (2021)
HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury
Si-Wei Tan et al.
JOURNAL OF NEUROINFLAMMATION (2021)
NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-β in sclerotic hippocampi
Eliana Cristina de Brito Toscano et al.
BRAIN RESEARCH (2021)
The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome
Joseph S. Bednash et al.
CELLULAR SIGNALLING (2021)
Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker
Leticia Moreno-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly
Tingting Niu et al.
NATURE COMMUNICATIONS (2021)
Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
Guohua Li et al.
FRONTIERS IN NEUROSCIENCE (2021)
P2X7 receptor/NLRP3 inflammasome complex and α-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-naive Parkinson's disease
Anna Solini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Dorit Trudler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Intracerebral Injection of Heme Induces Lipid Peroxidation, Neuroinflammation, and Sensorimotor Deficits
Luiz Ricardo C. Vasconcellos et al.
STROKE (2021)
The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis
Keith E. Campagno et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases
Bowen Zhou et al.
CELL REPORTS (2021)
Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
Federica Piancone et al.
FRONTIERS IN NEUROSCIENCE (2021)
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease
Dawn C. Matthews et al.
BRAIN (2021)
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies
Hannah Scheiblich et al.
JOURNAL OF IMMUNOLOGY (2021)
TBK1 and IKKe act like an OFF switch to limit NLRP3 inflammasome pathway activation
Fabian A. Fischer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88-and NLRP3-ASC-inflammasome pathway
Shanya Jiang et al.
CELL REPORTS (2021)
Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells
Chinmaya Panda et al.
CELLS (2021)
2,5-hexanedione induces NLRP3 inflammasome activation and neurotoxicity through NADPH oxidase-dependent pathway
Ruixue Huang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling
Shuting Zhang et al.
MOLECULAR PSYCHIATRY (2020)
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Vandana Deora et al.
GLIA (2020)
Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice
Jinbo Cheng et al.
AUTOPHAGY (2020)
An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance
Ming He et al.
CELL METABOLISM (2020)
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
Juan Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia
Asta Luciunaite et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease
Zheng Fan et al.
JOURNAL OF NEUROINFLAMMATION (2020)
A novel role for SHARPIN in amyloid-O phagocytosis and inflammation by peripheral blood -derived macrophages in Alzheimer's disease
Dhanya Krishnan et al.
NEUROBIOLOGY OF AGING (2020)
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis
Xue Zhang et al.
AGING-US (2020)
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Sunny Malhotra et al.
BRAIN (2020)
Mitochondrial DNA Promotes NLRP3 Inflammasome Activation and Contributes to Endothelial Dysfunction and Inflammation in Type 1 Diabetes
Camila A. Pereira et al.
FRONTIERS IN PHYSIOLOGY (2020)
Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer's Disease
Weigang Cui et al.
FRONTIERS IN NEUROSCIENCE (2020)
NLRP3 level in cerebrospinal fluid of patients with neuromyelitis optica spectrum disorders: Increased levels and association with disease severity
Yu Peng et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
Suwen Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease
Hayate Javed et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Signaling Through Purinergic Receptor P2Y2Enhances Macrophage IL-1β Production
Gonzalo de la Rosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
NEK7 Coordinates Rapid Neuroinflammation After Subarachnoid Hemorrhage in Mice
Gen Li et al.
FRONTIERS IN NEUROLOGY (2020)
Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer's Disease
Tengfei Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients
Filomena Iannuzzi et al.
CELLS (2020)
Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
Elisabeth Mulazzani et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Klotho overexpression improves amyloid-beta clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
Yue Zhao et al.
AGING CELL (2020)
New mechanism of neuroinflammation in Alzheimer's disease: The activation of NLRP3 inflammasome mediated by gut microbiota
Heping Shen et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy
Hui Hu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer's disease pathology
Daniel C. Shippy et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia
Yang Liu et al.
NEUROSCIENCE LETTERS (2020)
NLRP3 Is Involved in the Maintenance of Cerebral Pericytes
Wenqiang Quan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease
Xiao-fei He et al.
CELL DEATH & DISEASE (2020)
Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
Jie Li et al.
EXPERIMENTAL BRAIN RESEARCH (2020)
Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome
Wenbiao Wang et al.
BMC BIOLOGY (2020)
Galactosaminogalactan activates the inflammasome to provide host protection
Benoit Briard et al.
NATURE (2020)
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease
Niklas Lonnemann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll -like receptors 2 and 4
Pedro M. Moraes-Vieira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression
Hui Song et al.
NATURE COMMUNICATIONS (2020)
LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation
Jack P. Green et al.
ELIFE (2020)
Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease
Xinwen Zhang et al.
SCIENCE ADVANCES (2020)
Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?
Jack Rivers-Auty et al.
BRAIN COMMUNICATIONS (2020)
Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer's disease features in cortical neurons
Diana F. Silva et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Knocking down TRPM2 expression reduces cell injury and NLRP3 inflammasome activation in PC12 cells subjected to oxygen-glucose deprivation
Tao Pan et al.
NEURAL REGENERATION RESEARCH (2020)
A novel artificial intelligence protocol to investigate potential leads for Parkinson's disease
Zhi-Dong Chen et al.
RSC ADVANCES (2020)
MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
Eunju Lee et al.
CELL DEATH AND DIFFERENTIATION (2019)
ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
Guangming Ren et al.
EMBO JOURNAL (2019)
ApoE attenuates unresolvable inflammation by complex formation with activated C1q (vol 25, pg 496, 2019)
Changjun Yin et al.
NATURE MEDICINE (2019)
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease
Xiaojuan Han et al.
AUTOPHAGY (2019)
APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology
Tam T. T. Tran et al.
FASEB JOURNAL (2019)
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
Humayun Sharif et al.
NATURE (2019)
The relationship between inflammasomes and the endoplasmic reticulum stress response in the injured spinal cord
Sho Yanagisawa et al.
NEUROSCIENCE LETTERS (2019)
Alternative splicing regulates stochastic NLRP3 activity
Florian Hoss et al.
NATURE COMMUNICATIONS (2019)
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease
Si Zhang et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease A Randomized Clinical Trial
Christopher H. van Dyck et al.
JAMA NEUROLOGY (2019)
DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome
Parimal Samir et al.
NATURE (2019)
EK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury
Yuhua Chen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
NLRP3 inflammasome activation drives tau pathology
Christina Ising et al.
NATURE (2019)
Human immunodeficiency virus Type-1 single-stranded RNA activates the NLRP3 inflammasome and impairs autophagic clearance of damaged mitochondria in human microglia
Pratima Rawat et al.
GLIA (2019)
Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study
Koustav Chatterjee et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
Ilie-Cosmin Stancu et al.
ACTA NEUROPATHOLOGICA (2019)
NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model
Agnese Gugliandolo et al.
INFLAMMATION (2018)
Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression
Claudia Bartels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer's disease: Involvement of PI3-kinase, eNOS and NF kappa B
Manish Kumar et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
Ruth Knight et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)
Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop
Francois Mouton-Liger et al.
GLIA (2018)
HSP60 critically regulates endogenous IL-1 beta production in activated microglia by stimulating NLRP3 inflammasome pathway
Shalini Swaroop et al.
JOURNAL OF NEUROINFLAMMATION (2018)
NLRP3-dependent synaptic plasticity deficit in an Alzheimer's disease amyloidosis model in vivo
Yingjie Qi et al.
NEUROBIOLOGY OF DISEASE (2018)
Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway
Bingqing Cao et al.
NEUROSCIENCE (2018)
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
Tali Lang et al.
NATURE COMMUNICATIONS (2018)
Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer's Disease-Related Changes Through the Regulation of the Peripheral Immune System
Jiezhong Yu et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
Jack P. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
SUMO-mediated regulation of NLRP3 modulates inflammasome activity
Rachael Barry et al.
NATURE COMMUNICATIONS (2018)
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Jueqi Chen et al.
NATURE (2018)
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Richard Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system
Ayaka Nakanishi et al.
INFLAMMATION AND REGENERATION (2018)
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease
Katharine M. von Herrmann et al.
NPJ PARKINSONS DISEASE (2018)
Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice
Berthold Debye et al.
BRAIN PATHOLOGY (2018)
Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound
Narjes Baazaoui et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
Andrea Stutz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Protein kinase D at the Golgi controls NLRP3 inflammasome activation
Zhirong Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation
Nan Song et al.
MOLECULAR CELL (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats
Zhijuan Mao et al.
NEUROCHEMICAL RESEARCH (2017)
Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children
Jessica S. Wallisch et al.
NEUROCRITICAL CARE (2017)
Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?
Yun Zhang et al.
PROGRESS IN NEUROBIOLOGY (2017)
MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism
Xuan Li et al.
NATURE COMMUNICATIONS (2017)
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
Tiantian Tang et al.
NATURE COMMUNICATIONS (2017)
[18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease
Michelle L. James et al.
THERANOSTICS (2017)
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
Narjes Baazaoui et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease
Souvarish Sarkar et al.
NPJ PARKINSONS DISEASE (2017)
TDP-43 upregulation mediated by the NLRP3 inflammasome induces cognitive impairment in 2 2',4,4'-tetrabromodiphenyl ether (BDE-47)-treated mice
Juan Zhuang et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
C. Dempsey et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
Christina J. Gross et al.
IMMUNITY (2016)
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease
Marina Saresella et al.
MOLECULAR NEURODEGENERATION (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
Mausita Karmakar et al.
NATURE COMMUNICATIONS (2016)
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
Michael J. D. Daniels et al.
NATURE COMMUNICATIONS (2016)
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Adam C. Kaufman et al.
ANNALS OF NEUROLOGY (2015)
Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Adelin Gustot et al.
BIOCHEMICAL JOURNAL (2015)
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Yan-Le Xin et al.
BIOSCIENCE REPORTS (2015)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
Wan-ting He et al.
CELL RESEARCH (2015)
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Weihua Zhao et al.
EXPERIMENTAL NEUROLOGY (2015)
NLRP3 Inflammasome Is Expressed by Astrocytes in the SOD1 Mouse Model of ALS and in Human Sporadic ALS Patients
Sonja Johann et al.
GLIA (2015)
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki et al.
NATURE (2015)
Control of repeat-protein curvature by computational protein design
Keunwan Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Oxygen-glucose deprivation inducing B1 RNA inhibits neuronal cells metabolic activity by NLRP3 and associated proinflammatory cytokines production
Li Wang et al.
NEUROSCIENCE LETTERS (2015)
K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells
J. R. Yaron et al.
CELL DEATH & DISEASE (2015)
Control of repeat-protein curvature by computational protein design
Keunwan Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet
Islam N. Mohamed et al.
DIABETOLOGIA (2014)
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
Alberto Baroja-Mazo et al.
NATURE IMMUNOLOGY (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
Syed Faraz Kazim et al.
NEUROBIOLOGY OF DISEASE (2014)
Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells
Silvia Alfonso-Loeches et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human A beta-induced synaptic dysfunction in individual freely behaving pre- plaque transgenic rats: rapid reversal by anti-A beta agents
Yingjie Qi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
The Mitochondrial Antiviral Protein MAVS Associates with NLRP3 and Regulates Its Inflammasome Activity
Sangjun Park et al.
JOURNAL OF IMMUNOLOGY (2013)
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Benedicte F. Py et al.
MOLECULAR CELL (2013)
Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment
Laura H. Goldstein et al.
LANCET NEUROLOGY (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat Model
Huan-Dong Liu et al.
NEUROCHEMICAL RESEARCH (2013)
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease
B. Parajuli et al.
CELL DEATH & DISEASE (2013)
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Vincent Compan et al.
IMMUNITY (2012)
Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome Clinical article
Stephanie Adamczak et al.
JOURNAL OF NEUROSURGERY (2012)
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie et al.
LANCET NEUROLOGY (2012)
Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease
Kim J. Krishnan et al.
NEUROBIOLOGY OF AGING (2012)
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis
Makoto Inoue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor Protein
Cecile Delarasse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Non-canonical inflammasome activation targets caspase-11
Nobuhiko Kayagaki et al.
NATURE (2011)
Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice
Bin Li et al.
FEBS LETTERS (2010)
Structure and Interdomain Dynamics of Apoptosis-associated Speck-like Protein Containing a CARD (ASC)
Eva de Alba
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Toshiyuki Takahashi et al.
BRAIN (2007)
A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses
Annick Mayor et al.
NATURE IMMUNOLOGY (2007)
Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial
Arash Mowla et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Assessing therapeutic efficacy in a progressive disease - A study of donepezil in Alzheimer's disease
Peter Johannsen et al.
CNS DRUGS (2006)
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years
GW Small et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
L Agostini et al.
IMMUNITY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
B Seltzer et al.
ARCHIVES OF NEUROLOGY (2004)
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil
SI Finkel et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Mitochondrial abnormalities in Alzheimer's disease
K Hirai et al.
JOURNAL OF NEUROSCIENCE (2001)
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
GK Wilcock et al.
BRITISH MEDICAL JOURNAL (2000)
A 5-month, randomized, placebo-controlled trial of galantamine in AD
PN Tariot et al.
NEUROLOGY (2000)
Identification of a locus on chromosome 1q44 for familial cold urticaria
HM Hoffman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)